351 related articles for article (PubMed ID: 25387283)
1. Point-of-care testing for HCV infection: recent advances and implications for alternative screening.
Parisi MR; Soldini L; Vidoni G; Mabellini C; Belloni T; Brignolo L; Negri S; Schlusnus K; Dorigatti F; Lazzarin A
New Microbiol; 2014 Oct; 37(4):449-57. PubMed ID: 25387283
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: an Italian pilot study in a dental clinic.
Parisi MR; Tecco S; Gastaldi G; Polizzi E; D'Amicantonio T; Negri S; Gardini I; Schlusnus K; Gherlone E; Capparè P; Lazzarin A
New Microbiol; 2017 Oct; 40(4):242-245. PubMed ID: 28825443
[TBL] [Abstract][Full Text] [Related]
3. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
[TBL] [Abstract][Full Text] [Related]
4. Targeted hepatitis C screening among ex-injection drug users in the community.
Wong VW; Wong GL; Chim AM; Cheng TF; Cheung SW; Lai CM; Szeto KJ; Tsang S; Wu SH; Yan KK; Hui AY; Yiu DC; Wu BB; Cheung D; Chung CS; Lai CW; Chan HL
J Gastroenterol Hepatol; 2014 Jan; 29(1):116-20. PubMed ID: 24033786
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.
Lee SR; Kardos KW; Schiff E; Berne CA; Mounzer K; Banks AT; Tatum HA; Friel TJ; Demicco MP; Lee WM; Eder SE; Monto A; Yearwood GD; Guillon GB; Kurtz LA; Fischl M; Unangst JL; Kriebel L; Feiss G; Roehler M
J Virol Methods; 2011 Mar; 172(1-2):27-31. PubMed ID: 21182871
[TBL] [Abstract][Full Text] [Related]
6. Outcome of screening for hepatitis C virus infection based on risk factors.
Mallette C; Flynn MA; Promrat K
Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B and C in internally displaced persons of war against terrorism in Swat, Pakistan.
Rauf A; Nadeem MS; Ali A; Iqbal M; Mustafa M; Latif MM; Latif MZ; Ahmed N; Shakoori AR
Eur J Public Health; 2011 Oct; 21(5):638-42. PubMed ID: 20601693
[TBL] [Abstract][Full Text] [Related]
8. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
[TBL] [Abstract][Full Text] [Related]
9. Testing for HCV: the first step in preventing disease transmission and improving health outcomes for HCV-infected individuals.
Ward JW
Antivir Ther; 2012; 17(7 Pt B):1397-401. PubMed ID: 23321543
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C: Part I. Routine serologic testing and diagnosis.
Moyer LA; Mast EE; Alter MJ
Am Fam Physician; 1999 Jan; 59(1):79-88, 91-2. PubMed ID: 9917576
[TBL] [Abstract][Full Text] [Related]
11. Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settings.
Parisi MR; Soldini L; Vidoni G; Clemente F; Mabellini C; Belloni T; Nozza S; Brignolo L; Negri S; Rusconi S; Schlusnus K; Dorigatti F; Lazzarin A
New Microbiol; 2013 Apr; 36(2):121-32. PubMed ID: 23686118
[TBL] [Abstract][Full Text] [Related]
12. Point-of-care testing for hepatitis C virus infection at an Italian dental clinic: portrait of the pilot study population.
Tecco S; Parisi MR; Gastaldi G; Polizzi E; D'Amicantonio T; Zilocchi I; Gardini I; Gherlone EF; Lazzarin A; Capparè P
New Microbiol; 2019 Jul; 42(3):133-138. PubMed ID: 31157397
[TBL] [Abstract][Full Text] [Related]
13. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
14. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
Ahmad N; Asgher M; Shafique M; Qureshi JA
Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
[TBL] [Abstract][Full Text] [Related]
15. Acute hepatitis C: prevention and treatment.
Ozaras R; Tahan V
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis C.
Sherlock DS
Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
[TBL] [Abstract][Full Text] [Related]
17. Validation of a hepatitis C screening tool in primary care.
McGinn T; O'Connor-Moore N; Alfandre D; Gardenier D; Wisnivesky J
Arch Intern Med; 2008 Oct; 168(18):2009-13. PubMed ID: 18852403
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.
Zuure F; Davidovich U; Kok G; Depla AC; Hoebe C; van den Hoek A; Jansen PL; van Leeuwen-Gilbert P; Weegink CJ; Coutinho RA; Prins M
Euro Surveill; 2010 Apr; 15(15):19539. PubMed ID: 20429995
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
